AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, S. A.
Right arrow Articles by Adler, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, S. A.
Right arrow Articles by Adler, B.
Antimicrobial Agents and Chemotherapy, February 2003, p. 727-734, Vol. 47, No. 2
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.2.727-734.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Molecular Epidemiology of the SRL Pathogenicity Island

Sally A. Turner, Shelley N. Luck, Harry Sakellaris, Kumar Rajakumar,{dagger} and Ben Adler*

Bacterial Pathogenesis Research Group, Department of Microbiology, Monash University, Victoria 3800, Australia

Received 15 July 2002/ Returned for modification 17 October 2002/ Accepted 19 November 2002


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The Shigella resistance locus (SRL), which is carried on the SRL pathogenicity island (PAI) in Shigella flexneri 2a YSH6000, mediates resistance to the antibiotics streptomycin, ampicillin, chloramphenicol, and tetracycline. In the present study, we investigated the distribution and structural variation of the SRL and the SRL PAI in 71 Shigella isolates and 28 other enteric pathogens by PCR and Southern analysis. The SRL and SRL-related loci, although absent from the other enteric pathogens evaluated in this study, were found to be present in a number of Shigella isolates. SRL PAI markers were also present in the majority of strains carrying the SRL and SRL-related loci. PCR linkage studies with six of these strains demonstrated that the SRL is carried on elements similar in structure and organization to the YSH6000 SRL PAI, consistent with the hypothesis that the SRL PAI may be involved in the spread of multiple-antibiotic resistance in these strains.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Shigella spp. are a common cause of bacillary dysentery and are responsible for the deaths of more than 1 million people annually, the majority of which occur in developing countries (23). Infection is transmitted via the fecal-oral route and is characterized by excretion of stools containing white cells and blood (9). Shigellosis is one of the few enteric infections for which antimicrobial therapy is clearly effective. Although treatment with antibiotics has not been shown to reduce the rate of mortality (41), it does reduce both the duration and the severity of illness and the duration of pathogen excretion (14), which are important considerations in the prevention of further transmission. However, over the past several decades treatment has become increasingly difficult due to emerging resistance to most of the widely used antibiotics (22, 41).

Resistance in Shigella to multiple antibiotics such as sulfonamides (SULs), streptomycin (STR), ampicillin (AMP), chloramphenicol (CHL), and tetracycline (TET) was first reported in Japan shortly after their introduction as therapeutic agents for the treatment of shigellosis. In the majority of cases, resistance was found to be borne on conjugative R plasmids, and the inherent mobility of R plasmids was thought to explain the rapid increase in the number of multiply resistant Shigella strains observed during the 1950s (49). NR1, the archetypal Shigella R plasmid, which encodes resistance to mercury, SULs, STR, CHL, and TET, was isolated during that period (30, 51). Recently, in addition to plasmid-borne resistance, there have been several reports of chromosomally borne resistance (7, 10, 25). However, the basis of chromosomal resistance in Shigella has remained largely unexplored.

In 1997, Rajakumar et al. (36) reported on the identification of a chromosomal multiantibiotic resistance locus in Shigella flexneri 2a strain YSH6000. This locus, which has since been designated the Shigella resistance locus (SRL), encodes resistance to STR, AMP, CHL, and TET and exhibits both organizational and sequence similarity to corresponding regions of NR1. However, the SRL also exhibits several differences from NR1, including the absence of the mercury and SUL resistance determinants, a 17.5-kb deletion between the CHL and TET resistance determinants, and the precise insertion of a ß-lactamase-encoding oxa-1 cassette into the Tn21-borne integron In2 (26, 36). Although insertion of the oxa-1 cassette into this location of Tn21 has been demonstrated experimentally (45) and is observed in the closely related plasmid-borne transposon Tn2603 (32), the unique combination and placement of resistance determinants distinguishes the SRLs even from these close relatives (36).

The SRL was originally reported to reside on a 99-kb deletable element which has since been designated the multiple-antibiotic-resistance deletable element (MRDE) (37, 46). Recent studies have revealed that the 16.7-kb IS1-flanked SRL is borne on a 66-kb pathogenicity island (PAI), designated the SRL PAI (26). The SRL is lost from S. flexneri 2a strain YSH6000 via three distinct but separate mechanisms involving deletion of the SRL itself, integrase-mediated deletion of the PAI, and deletion of the MRDE (an IS91-flanked element encompassing the SRL PAI and some surrounding chromosomal DNA). All deletions result in the loss of the SRL from the chromosome (46). As the IS1-flanked r determinant of NR1 and PAIs are mobile in other systems, it was considered that there was potential for dissemination of SRL within Shigella via one of these mechanisms (46). In this study, we present evidence that the resistance conferred by the SRL is widespread among clinical Shigella isolates and that dissemination of the SRL may be mediated by the SRL PAI.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Bacterial strains, media, and growth conditions. The bacterial strains used in this study are listed in Table 1. The strains were routinely grown at 37°C in Luria-Bertani (LB) medium (3), with the addition of AMP (100 µg/ml), STR (25 µg/ml), CHL (40 µg/ml), or TET (10 µg/ml) when necessary.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Bacterial strains

 
Molecular biological techniques. Genomic DNA was isolated by use of a small-scale preparation as described previously (3). Plasmid DNA was isolated by a modification of the alkaline lysis method (28).

Selection of TET-sensitive derivatives of SBA1299 and SBA1391. TET-sensitive derivatives were selected by plating dilutions of cultures grown in LB broth to densities of approximately 109 CFU ml-1 onto LB agar supplemented with fusaric acid (12 µg/ml), heat-inactivated chlortetracycline (50 µg/ml), and 0.1 mM ZnCl2 (27). The agar plates were incubated for 24 to 40 h at 37°C.

Southern hybridization. After electrophoresis, DNA was transferred to a charged nylon membrane (Roche) by using a vacuum blotting apparatus (TE80 Transvac; Hoefer) or by capillary transfer in 20x SSC (750 mM NaCl plus 75 mM sodium citrate [pH 7.0]). Overnight hybridization and subsequent washings were performed under high-stringency conditions at 68°C, as recommended in the instructions supplied with the Roche digoxigenin labeling and detection kit. Probes were labeled by PCR amplification with digoxigenin as specified by Roche. The 1.0-kb int probe and the 1.0-kb fec probe were amplified as described previously (46). The 0.2-kb oxa-1 probe was amplified with primers BAP1553 and BAP1559 (Table 2).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Primers used in this study

 
PCR amplification and linkage of SRL PAI markers. PCR amplifications were performed with chromosomal DNA by using the Taq DNA polymerase system, as specified by Roche. PCR amplifications of DNA fragments of over 5.0 kb were performed with Expand Long Template PCR buffer system 3, as specified by Roche. Colony PCRs were performed with single colonies added directly to the PCR mix, with an initial 8 min of incubation at 94°C

Separation of plasmid and chromosomal DNAs. Plasmid and chromosomal DNAs were separated by using a modification of the Eckhardt in-well lysis method (35). Approximately 107 to 108 cells were resuspended in lysozyme mixture (7% Ficoll, 20% sucrose, 1 U of RNase per ml, and 1 mg of lysozyme per ml in Tris-borate-EDTA [TBE]) and loaded into the wells of 0.4 and 0.8% agarose gels. The samples were then overlaid with a sodium dodecyl sulfate mixture (1% sodium dodecyl sulfate and 5% sucrose bromophenol blue in TBE) and electrophoresed for 30 min at 5 mA, followed by electrophoresis for 2 h at 100 mA.

Computer analysis. Searches of databases for nucleotide sequences with sequence similarities were performed with the BlastN or BlastX program (2). Sequence data were analyzed with the Sequencher program (GeneCodes Corporation, Ann Arbor, Mich.).


   RESULTS
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Distribution of the SRL among Shigella isolates. To determine whether the combination of drug resistance encoded by the SRL was present in other Shigella species, 71 clinical Shigella isolates including representatives from 27 different serotypes were tested for their ability to grow in the presence of STR, AMP, CHL, and TET. Of these strains, 31 were found to be resistant to all four antibiotics, including strains from each Shigella species (strains listed in Table 3). To establish whether resistance to these antibiotics was due to the presence of the SRL or other resistance loci, PCRs linking the coding region of aadA1 (Strr) with oxa-1 (Ampr), the coding region oxa-1 with catA (Chlr), and the coding region catA with tetA(B) (Tetr) (Fig. 1A) were performed with all isolates exhibiting resistance to the four antibiotics. These linkages enabled a distinction to be made between the SRL and the closely related resistance locus of NR1, as the NR1 locus does not contain the oxa-1 cassette and carries an additional ~17.5 kb between the cat and tetA(B) sequences (36). Physical linkage of all four determinants was demonstrated in the majority (22 of 31) of strains (Table 4), indicating conservation of the genetic organization of the YSH6000 SRL in these isolates. With the exception of one strain in which no linkages were demonstrated, all strains exhibited linkage of two or three resistance determinants (Table 4), suggesting the presence of a locus either that was identical to or that shared some similarity with the organization of the YSH6000 SRL.


View this table:
[in this window]
[in a new window]
  		TABLE 3. Distribution of SRL PAI markers in Strr Ampr Chlr Tetr Shigella isolates

 


View larger version (19K):
[in this window]
[in a new window]
  		FIG. 1. Schematic representation of the genetic organization of the SRL PAI in strain YSH6000. (A) The SRL PAI is represented as a thin black line, with the positions and directions of relevant genes and open reading frames represented as arrows. The SRL is indicated by the large shaded box. Thick lines represent the regions amplified in linkage analysis of the SRL, with the corresponding numbers indicating their sizes (in kilobases) in the YSH6000 SRL PAI. Small black boxes represent the positions of the markers that were probed by Southern analysis or PCR amplification: box A, int; box B, fecA; and box C, orf58. (B) Thick black lines represent the regions amplified in linkage analyses of SBA1299 (S. flexneri 1a), SBA1303 (S. sonnei form I), SBA1304 (S. dysenteriae 3), SBA1308 (S. boydii 4), SBA1386 (S. boydii 8), and SBA1391 (S. flexneri 4a), with the corresponding numbers indicating their sizes (in kilobases).

 

View this table:
[in this window]
[in a new window]
  		TABLE 4. Linkage of resistance determinants in Strr Ampr Chlr Tetr Shigella isolates

 
Distribution of the SRL PAI markers among Shigella isolates. In order to discover whether the SRL-related loci were present as part of the SRL PAI or as independent loci, strains were tested for the presence of three SRL PAI markers. Probes corresponding to the integrase gene (int), which has been shown to be necessary for deletion of the SRL PAI (46) (Fig. 1A, region A), and fecA, a critical component of the fec iron transport locus (47) (Fig. 1A, region B), were used in a high-stringency Southern analysis of the 31 Strr Ampr Chlr Tetr strains (Table 3). Additionally, primers amplifying a region internal to orf58 of the SRL PAI (26), which has no database matches at the nucleotide level, were used to analyze these strains by PCR (Fig. 1A, region C; Table 3).

The results indicated that sequences homologous to the SRL PAI int were present in all but 2 of the 31 Strr Ampr Chlr Tetr strains, and with one exception, multiresistant strains that carry the int marker also carry the orf58 marker (Table 3). Interestingly, SBA1298 and SBA1388, the only two Strr Ampr Chlr Tetr int-negative strains identified, were among the strains that showed the least similarity to the SRL in SRL linkage studies (Table 4). Thus, in the majority of strains that contain the int marker, resistance to STR, AMP, CHL, and TET (100% of strains; in 28 of 29 strains the resistance is SRL related) and the orf58 marker (97% of strains) are also present, suggesting that the resistance determinants in these strains are borne on elements similar to the SRL PAI. Moreover, the int marker was absent from the other 40 strains, indicating a perfect correlation between the presence of int and resistance to the four antibiotics (data not shown). Interestingly, the orf58 marker was present in 24% of the 42 strains negative for the int marker (data not shown). The majority of strains that possessed the int marker were also positive for the fecA marker (69%) (Table 3). However, 45% of the int-negative strains also possessed the fecA marker (data not shown). These data and the finding that fec is a chromosomal locus in the closely related strain Escherichia coli K-12 (19) make it difficult to assess whether fecA is consistently carried on the SRL PAI in int-positive strains.

The SRL PAI is widespread among Strr Ampr Chlr Tetr Shigella isolates. In order to examine whether the presence of the SRL PAI markers in the Strr Ampr Chlr Tetr isolates indicated the presence of an intact, ordered set of genes representing the SRL PAI, a representative of each Shigella species was chosen for further characterization. Genomic DNA from the following strains was analyzed by PCR for physical linkage of 13 loci spanning the YSH6000 SRL PAI: SBA1299 (S. flexneri 1a), SBA1303 (S. sonnei form I), SBA1308 (S. boydii 4), and SBA1391 (S. flexneri 4a), which are positive for the int, fecA, and orf58 markers, and SBA1304 (S. dysenteriae 3) and SBA1386 (S. boydii 8), which are positive for the int and orf58 markers but negative for the fecA marker (Fig. 1). In strains SBA1299, SBA1308, and SBA1391, physical linkage of all 13 loci was demonstrated, revealing the presence of elements that appear to have a structure similar to that of the YSH6000 SRL PAI (Fig. 1). All loci with the exception of orf45 and orf48 were also linked in strain SBA1303 (Fig. 1). As orf45 and orf48 sequences bearing the amplifying primer binding sites were present in SBA1303 (data not shown), it was considered likely that the insertion of additional DNA may account for the failure to amplify this region. Although the PCR extension times were increased to allow the amplification of 12- to 14-kb products, no products were amplified, implying that either the loci are not linked or these regions exceed 14 kb. In SBA1304 and SBA1386, which were negative for the fecA marker, all loci except for a large region extending from tetC to orf48 were linked (Fig. 1). Thus, it appears that absence of the fecA marker may correspond to the absence of a larger region in both SBA1304 and SBA1386. Hence, despite minor differences in linkage patterns and sizes, these data demonstrate the presence of elements in all four Shigella species that have structures similar to those of the S. flexneri 2a strain YSH6000 SRL PAI.

To test whether these SRL PAI-like elements were plasmid or chromosomally borne, Eckhardt gel electrophoresis was performed with these six strains and DNA was analyzed by Southern hybridization with a cat gene-specific probe (data not shown). The results confirmed a chromosomal location for the cat gene (and, therefore, the SRL PAI-like elements) in each of the six Shigella isolates. In contrast, strains SBA1298 (S. flexneri 3c) and SBA1388 (S. flexneri 2a), in which resistance to STR, AMP, CHL, and TET was not thought to be related to the presence of the SRL PAI because of the absence of an int gene, possessed a plasmid-borne cat gene.

Chromosomal deletion of the SRL locus. The SRL PAI is known to undergo precise, integrase-mediated deletion from the chromosome in S. flexneri 2a strain YSH6000. This deletion can be identified by selection of strains on fusaric acid medium, followed by PCR amplification of the deletion point junction (46). To determine whether the elements in SBA1299, SBA1303, SBA1304, SBA1308, SBA1386, and SBA1391 were capable of undergoing similar deletions, these strains were also grown on fusaric acid medium. However, only strains SBA1299 (S. flexneri 1a) and SBA1391 (S. flexneri 4a) were found to be fusaric acid sensitive and therefore to be suitable for selection of the loss of the PAI by this method. Tets derivatives of SBA1299 and SBA1391 obtained by this selection method were subsequently tested for their susceptibilities to the antibiotics STR, AMP, and CHL. All SBA1299 derivatives were found to be Strr and were thought to possess some additional determinant other than the SRL aadA1 gene conferring this resistance. Thus, 10 Strr Amps Chls Tets SBA1299 derivatives and 2 SBA1391 Strs Amps Chls Tets derivatives were considered potential PAI deletants and were therefore selected for PCR characterization. However, amplification of serX, at the SRL PAI deletion point junction, was not successful for any of the SBA1299 and SBA1391 derivatives, suggesting that precise deletion of the element had not occurred.

Each derivative was tested by PCR for the presence of the markers int, fecA, and orf58. Nine SBA1299 derivatives and both of the SBA1391 derivatives were negative for all of these markers and were therefore consistent with PAI deletants. The deletion derivatives were further tested by PCR for the presence of the chromosomally borne csgA gene, which is approximately 7 kb downstream of orf58 in YSH6000. This gene was absent from all nine SBA1299 derivatives and both of the SBA1391 derivatives, indicating that DNA flanking the PAI-like element was also deleted with the PAI markers. In YSH6000, imprecise deletion of the SRL PAI, which removes flanking chromosomal DNA including the csgA gene, occurs from the mdoA and the putA loci due to the presence of flanking IS91 elements on the chromosome (46). The deletion of this region, known as the MRDE, was tested by PCR amplification across the deletion point junction identified in YSH6000. This amplification was positive for four of the SBA1299 derivatives and both of the SBA1391 derivatives, demonstrating that deletion events similar to MRDE deletion in YSH6000 had occurred in at least six of the derivative strains (data not shown). In strains in which the MRDE deletion point junction was not amplified, it is likely that loss of the PAI markers occurs by another type of deletion mechanism. As insertion sequence (IS) elements have been implicated in deletion of part or all of the SRL PAI in strain YSH6000 (46), it is possible that additional IS elements present in SBA1299 may be involved in the deletion of the SRL PAI from these strains.

Distribution of the SRL PAI among other members of the family Enterobacteriaceae. The dissemination of the SRL PAI throughout many Shigella species, in conjunction with the report that the Yersinia high-PAI (HPI) is present in different members of the family Enterobacteriaceae (43, 44), prompted the investigation of several other enteric pathogens for the presence of the SRL PAI. Twenty-eight members of the family Enterobacteriaceae including representatives of enteroinvasive E. coli (EIEC), enterohemorrhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), Salmonella enterica serovar Typhimurium, and Yersinia enterocolitica were tested for antibiotic resistance. Among the 28 strains, only a single Y. enterocolitica strain was found to have a Strr Ampr Chlr Tetr phenotype. However, PCR linkage of the SRL determinants was not achieved in this strain, suggesting that the resistance profile was not due to the presence of the SRL.

Isolates were also tested for the presence of int and fecA by Southern hybridization and for the presence of orf58 by PCR. fecA was detected in one EIEC, two ETEC, and three EAEC strains, while orf58 was detected in four EIEC strains and one EHEC strain. Regions hybridizing to the int probe were found in two EHEC strains and one EPEC strain (data not shown). Recent sequencing of the EHEC O157:H7 EDL 933 genome revealed the presence of a 1,203-bp orf, present on identical O islands (O islands 43 and 48), whose sequence is nearly identical to that of the SRL PAI int gene (33). These genes share 97% nucleotide sequence identity over the first 1,189 bp but diverge abruptly after that point. PCR amplification with primers designed to anneal to this divergent region confirmed that the int-positive EPEC and EHEC strains identified in this study yielded an amplification product with primers specific for the EHEC integrase gene but not with primers specific for the SRL PAI int gene (data not shown).

Chromosomal insertion sites of the SRL PAI-related elements. The YSH6000 SRL PAI was found to be inserted into the 3' end of the tRNA gene serX, and the int gene was situated adjacent to the 14-bp direct repeat with a sequence identical to that of the 3' terminus of the serX gene (26). By pairing a primer situated in the int gene with one downstream of serX, the presence of the SRL PAI in this position may be confirmed by PCR. This method was used to test the 29 int-positive Shigella strains (Table 3) and revealed that in 13 of these strains, int was linked to serX. E. coli possesses a paralog of serX, serW, at minute 20. At the nucleotide level, serW displays 100% identity to serX and thus also contains the 14-bp sequence thought to be targeted by the SRL PAI integrase (26, 46). As it has been noted that the HPI and the she PAI are also found to be inserted into different paralogs of the asn and phe tRNA genes, respectively (1, 6), the Shigella isolates were also tested for linkage of int to a sequence downstream of serW. Ten strains were found to be positive for this association (Table 3). Six strains were tested for the linkage of orf58 at the right end of the PAI to sequences upstream of both tRNA genes, but linkages could not be demonstrated. Five strains exhibited linkage of orf58 to sequences upstream of serX (Table 3). In the remaining one strain, both int and orf58 were not found to be linked to either the serX or the serW sequence. Interestingly, in the two int-positive EHEC strains, int was linked to serX and serW, and in the int-positive EPEC strain, int was linked to serX (data not shown).


   DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In this study we have demonstrated that loci showing similarity to the SRL, which mediates resistance to STR, AMP, CHL, and TET, are widespread among Shigella isolates of all four species. Additionally, the S. flexneri 2a strain YSH6000 SRL PAI int and orf58 markers were found to be correlated with these loci, suggesting that the SRL PAI may be linked to the dissemination of the SRL throughout Shigella species. PCR linkage analysis revealed that the SRL PAI is essentially conserved in organization in these strains, although some variation was observed. Interestingly, the fec locus, which is present on the YSH6000 SRL PAI, is not always present in strains that carry the SRL-related loci and other SRL PAI markers. PCR linkage analysis of two such strains revealed that although the majority of the PAI organization and structure was conserved, the absence of the same region which spans the entirety of the fec locus and some surrounding sequences was observed in both isolates. Thus, it appears that the fec locus may have been lost from these strains or that these elements may represent a fec-negative predecessor of the SRL PAI. The absence of the same fec-carrying regions from these strains and the fact that the locus is flanked with phage and IS-related sequences (26), together with the presence of fec markers in PAI-negative Shigella isolates and its sporadic distribution throughout E. coli (15, 19, 34; this study), may suggest that the fec locus is independently mobile. Interestingly, orf58, which was found to be present in 97% of int-positive Shigella strains, was also present in 11% of int-negative strains. As orf58 exhibits some similarity to the IS1328 transposase of Y. enterocolitica (26), it is possible that the presence of this marker in int-negative strains may be due to its independent mobility.

Structural variation is not unique to the SRL PAI and is also found at one end of the Yersinia HPI (38) and the Shigella she PAI (1). Interestingly, unlike the she PAI, which has a great deal of diversity in structure, there appear to be few structural SRL PAI variants in Shigella, on the basis of the results obtained with the markers tested. The extraordinarily high degree of correlation between the presence of the int locus and the presence of SRL-related loci is dissimilar to the case for the Vibrio cholerae PAI-like SXT element, in which the presence of int sequences of the element was found to be associated with the presence of a variety of different multiresistance gene clusters (16). Interestingly, previous studies have demonstrated that the IS1-flanked YSH6000 SRL is capable of independent excision from the SRL PAI, a phenomenon which might allow its independent spread (46). However, thus far there have been no SRL-positive isolates that do not carry the SRL PAI int marker, suggesting that the SRL PAI acquired the SRL before widespread dissemination or that there is a strong selective pressure to maintain the SRL as part of the SRL PAI.

In this study, by using primers specific for the gene encoding the EHEC int O islands 43 and 48, which are remarkably similar to the SRL PAI int, sequences were amplified from two Strs Amps Chls Tets EHEC isolates and one Strs Amps Chls Tets EPEC isolate. The identical O islands 43 and 48 do not encode antibiotic resistance but show the same insertion specificity, and like the SRL PAI in YSH6000, they are also flanked by the same 14-bp direct repeat which corresponds to the 3' ends of the serX and serW tRNA genes (33). As we have determined that the SRL PAI may also occupy both of these sites in the Shigella chromosome, the considerable similarity between these integrases appears to be sufficient to confer the insertion site specificities of both elements. Excluding this int sequence similarity, the EHEC O islands show no nucleotide sequence similarity to the SRL PAI. However, analysis of open reading frames revealed that the EHEC O islands and the SRL PAI share a common backbone, and on the basis of this similarity, it appears likely that both the SRL and fec regions were acquired as distinct elements by the SRL PAI. It is interesting that although O islands 43 and 48 exist in some E. coli strains, the SRL-encoded multiple antibiotic resistance was never correlated with these markers in the E. coli strains investigated. The SRL PAI markers orf58 and fecA were also present in some E. coli isolates in this study. However, as discussed above, orf58 shows some similarity to an IS element transposase and the fec locus is a common chromosomal marker in E. coli; therefore, their presence in these strains was not unexpected. Hence, although several enteric pathogens possess markers of the SRL PAI, no one strain contained more than a single marker, suggesting that the SRL PAI is not present in the strains tested in this study. Thus, although elements bearing resemblance to the YSH6000 SRL PAI are relatively common in Shigella, it appears that similar elements are not present in the other enteric pathogens. Such a genus-specific distribution is in contrast to the HPI, which is found to be widely distributed throughout the members of the family Enterobacteriaceae (8, 21, 43, 44, 52). It is possible that the early and extensive use of antibiotics for the treatment of Shigella infections may have influenced the distribution of the SRL PAI. It would be interesting to determine whether SRL PAI-related elements were present in enterobacterial strains isolated before the introduction of antibiotic therapy, as it has been noted that conjugative plasmids which presumably gave rise to R plasmids were quite common in enterobacteria of the preantibiotic era (18).

It is generally believed that PAIs have been transferred horizontally (11-13, 24). However, such transfer has been demonstrated only for the PAI-like V. cholerae self-transmissible conjugative SXT element (17), the V. cholerae VPI, and the staphylococcal SaPI (20, 40). Although horizontal transfer of the SRL PAI has not been demonstrated, previous studies have shown that it undergoes site-specific, integrase-dependent deletion from the chromosome (46). Additionally, this element appears to be widespread throughout Shigella, appears to be absent from some Shigella and E. coli strains, and may occupy at least two distinct chromosomal loci. Together, these data support the hypothesis that the SRL PAI is, or was, mobile at some point. If this hypothesis is correct, PAIs may be an additional mechanism of antibiotic resistance spread.

It is interesting that the SRL itself incorporates components of plasmid-, transposon-, and integron-encoded resistance determinants, being composed of loci that resemble the NR1 plasmid r determinant, various transposons (including Tn2670, Tn21, and Tn10), and the Tn21-borne integron In2, which bears an additional oxa-1 gene cassette (26, 36). Indeed, a clinical study of isolates of the family Enterobacteriaceae noted that in addition to integron-borne antibiotic resistance, an association existed between the presence of integrons and non-integron-borne resistance genes. This genetic linkage of integrons with non-integron-borne factors encoding resistance to older antibiotics such as CHL and TET (50) is exemplified by the SRL and suggests that similar loci may be more common throughout the family Enterobacteriaceae.

Multiantibiotic resistance was originally reported to be plasmid borne (49) and is still considered to be the primary form of resistance in Shigella isolates. However, we have demonstrated linkage of the SRL PAI int to the chromosomal markers serX and serW in the majority of strains that carry the SRL-related loci, suggesting that these resistance determinants are not plasmid borne but reside on the chromosome. Further characterization of six such strains illustrated that the PAI-borne SRL was indeed situated on the chromosome. Additionally, there have been increasing reports of chromosomally linked determinants of resistance to multiple antibiotics, especially AMP, CHL, TET, and STR (7, 10, 25). A study from Somalia reported that all but 3 of 112 S. flexneri strains isolated between 1983 and 1989 carry chromosomally linked determinants for resistance to the antibiotics AMP, CHL, TET, and spectinomycin (7). Both spectinomycin resistance and STR resistance are conferred by the aadA1 cassette (36). Similarly, a study from Tanzania reported that the common combination of resistance to AMP, CHL, and TET was not directly related to plasmid profiles and that AMP resistance was usually due to the presence of oxa-1 (31). Previously, oxa-1-mediated AMP resistance was less common in gram-negative bacteria than resistance mediated by TEM ß-lactamases (39). Importantly, these data indicate that chromosomal loci bearing some resemblance to the PAI-borne SRL not only are present in the Japanese and Australian isolates investigated in this study but also may be prevalent in a wider range of Shigella strains distributed globally.

The SRL PAI is the first PAI to be linked with antibiotic resistance in a wide variety of bacterial strains. However, resistance to the antibiotics sulfamethoxazole, trimethoprim, and STR are encoded on the PAI-like SXT element (48), while Salmonella genomic island 1, which has been detected in a few Salmonella serovars, also encodes multidrug resistance (4, 5). Thus, dissemination of antibiotic resistance genes on PAIs and PAI-like elements may be an important mechanism of horizontal transfer not only among Shigella isolates but also within other bacterial populations. The clinical implications of such transfer are potentially serious, as selection for these elements poses the danger not only of increasing the prevalence of multiantibiotic resistance but also of changing the virulence profiles of such strains.


   ACKNOWLEDGMENTS
 
The technical assistance of Ian McPherson and Vicki Vallance is gratefully acknowledged.

This work was supported by a grant from the National Health and Medical Research Council, Canberra, Australia.


   FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology, Monash University, P.O. Box 53, Victoria 3800, Australia. Phone: (61 3 99054815). Fax: (61 3 99054811). E-mail: Ben.Adler {at}med.monash.edu.au. Back

{dagger} Present address: Department of Microbiology and Immunology, University of Leicester, Leicester LE1 9HN, United Kingdom. Back


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Al-Hasani, K., B. Adler, K. Rajakumar, and H. Sakellaris. 2001. Distribution and structural variation of the she pathogencity island in enteric bacterial pathogens. J. Med. Microbiol. 50:780-786.[Abstract/Free Full Text]
  2. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.[Abstract/Free Full Text]
  3. Ausubel, F. A., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1993. Current protocols in molecular biology. Greene Publishing and Wiley Interscience, New York, N.Y.
  4. Boyd, D., G. A. Peters, A. Clockaert, K. S. Boumedine, E. Chaslus-Dancla, H. Imberechts, and M. R. Mulvey. 2001. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica SerovarTyphimurium DT104 and its identification in phage type DT120 and serovar Agona. J. Bacteriol. 183:5725-5732.[Abstract/Free Full Text]
  5. Boyd, D. A., G. A. Peters, L.-K. Ng, and M. R. Mulvey. 2000. Partial characterization of a genomic island associated with the multidrug resistance region of Salmonella enterica Typhymurium DT104. FEMS Microbiol. Lett. 189:285-291.[CrossRef][Medline]
  6. Buchrieser, C., R. Brosch, S. Bach, A. Guiyoule, and E. Carniel. 1998. The high-pathogenicity island of Yersinia pseudotuberculosis can be inserted into any of the three chromosomal asn tRNA genes. Mol. Microbiol. 30:965-978.[CrossRef][Medline]
  7. Casalino, M., M. Nicoletti, A. Salvia, B. Colonna, C. Pazzani, A. Calconi, K. A. Mohamud, and F. Maimone. 1994. Characterization of endemic Shigella flexneri strains in Somalia: antimicrobial resistance, plasmid profiles, and serotype correlation. J. Clin. Microbiol. 32:1179-1183.[Abstract/Free Full Text]
  8. Clermont, O., S. Bonacorsi, and E. Bingen. 2001. The Yersinia high-pathogenicity island is highly predominant in virulence-associated phylogenetic groups of Escherichia coli. FEMS Microbiol. Lett. 196:153-157.[CrossRef][Medline]
  9. DuPont, H. L., M. M. Levine, R. B. Hornick, and S. B. Formal. 1989. Inoculum size in shigellosis and implications for expected mode of transmission. J. Infect. Dis. 159:1126-1128.[Medline]
  10. Gebre-Yohannes, A., and B. S. Drasar. 1990. Plasmid profiles of antibiotic-resistance Shigella dysenteriae types 2, 3, 4, 6 and 7 isolated in Ethiopia during 1976-85. Epidemiol. Infect. 105:65-72.[Medline]
  11. Hacker, J., G. Blum-Oehler, I. Muhldorfer, and H. Tschape. 1997. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol. Microbiol. 23:1089-1097.[CrossRef][Medline]
  12. Hacker, J., and J. B. Kaper. 1999. The concept of pathogenicity islands, p. 1-11. In J. B. Kaper and J. Hacker (ed.), Pathogenicity islands and other mobile virulence elements. American Society for Microbiology, Washington, D.C.
  13. Hacker, J., and J. B. Kaper. 2000. Pathogenicity islands and the evolution of microbes. Annu. Rev. Microbiol. 54:641-679.[CrossRef][Medline]
  14. Haltalin, K. C., J. D. Nelson, R. D. Ring, M. Sladoje, and L. V. Hinton. 1967. Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo. J. Pediatr. 70:970-981.[CrossRef][Medline]
  15. Hayashi, T., K. Makino, M. Ohnishi, K. Kurokawa, D. Ishii, K. Yokoyama, C.-G. Han, E. Ohtsubo, K. Nakayama, T. Murata, M. Tanaka, T. Tobe, T. Iida, H. Takami, T. Honda, C. Sasakawa, N. Ogasawara, T. Yasunaga, S. Kuhara, T. Shiba, M. Hattori, and H. Shinagawa. 2001. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 8:11-22.[Abstract]
  16. Hochhut, B., Y. Lotfi, D. Mazel, S. M. Faruque, R. Woodgate, and M. K. Waldor. 2001. Molecular analysis of antibiotic resistance gene clusters in Vibrio cholerae O139 and O1 SXT constins. Antimicrob. Agents Chemother. 45:2991-3000.[Abstract/Free Full Text]
  17. Hochhut, B., and M. K. Waldor. 1999. Site-specific integration of the conjugal Vibrio cholerae SXT element into prfC. Mol. Microbiol. 32:99-110.[CrossRef][Medline]
  18. Hughes, V. M., and N. Datta. 1983. Conjugative plasmids in bacteria of the 'pre-antibiotic' era. Nature 302:725-726.[CrossRef][Medline]
  19. Hussein, S., K. Hantke, and V. Braun. 1981. Citrate-dependent iron transport system in Escherichia coli K-12. Eur. J. Biochem. 117:431-437.[Medline]
  20. Karaolis, D. K. R., S. Somara, D. R. Maneval, Jr., J. A. Johnson, and J. B. Kaper. 1999. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature 399:375-379.[CrossRef][Medline]
  21. Karch, H., S. Schubert, D. Zhang, W. Zhang, H. Schmidt, T. Olschlager, and J. Hacker. 1999. A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect. Immun. 67:5994-6001.[Abstract/Free Full Text]
  22. Khan, M. U. 1985. Fourteen years of shigellosis in Dhaka: an epidemiological analysis. Int. J. Epidemiol. 14:607-613.[Abstract/Free Full Text]
  23. Kotloff, K. L., J. P. Winickoff, B. Ivanoff, J. D. Clemens, D. L. Swerdlow, P. J. Sansonetti, G. K. Adak, and M. M. Levine. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. W. H. O. 77:651-665.[Medline]
  24. Lee, C. A. 1996. Pathogenicity islands and the evolution of bacterial pathogens. Infect. Agents Dis. 5:1-7.[Medline]
  25. Ling, J. M., P. C. Shaw, K. M. Kam, A. F. Cheng, and G. L. French. 1993. Molecular studies of plasmids of multiply-resistant Shigella spp. in Hong Kong. Epidemiol. Infect. 110:437-446.[Medline]
  26. Luck, S. N., S. A. Turner, H. Sakellaris, K. Rajakumar, and B. Adler. 2001. Ferric dicitrate transport system (Fec) of Shigella flexneri 2a YSH6000 is encoded on a novel pathogenicity island carrying multiple antibiotic resistance genes. Infect. Immun. 69:6012-6021.[Abstract/Free Full Text]
  27. Maloy, S. R., and W. D. Nunn. 1981. Selection for loss of tetracycline resistance by Escherichia coli. J. Bacteriol. 145:1110-1112.[Abstract/Free Full Text]
  28. Morelle, G. 1989. A plasmid extraction procedure on a mimiprep scale. Focus 11:7-8.
  29. Nakata, N., C. Sasakawa, N. Okada, T. Tobe, I. Fukuda, T. Suzuki, K. Komatsu, and M. Yoshikawa. 1992. Identification and characterization of virK, a virulence-associated large plasmid gene essential for intercellular spreading of Shigella flexneri. Mol. Microbiol. 6:2387-2395.[Medline]
  30. Nakaya, R., A. Nakamura, and Y. Murata. 1960. Resistance transfer agents in Shigella. Biochem. Biophys. Res. Commun. 3:654-659.[CrossRef][Medline]
  31. Navia, M. M., L. Capitano, J. Ruiz, M. Vargas, H. Urassa, D. Schellemberg, J. Gascon, and J. Vila. 1999. Typing and characterization of mechanisms of resistance of Shigella spp. Isolated from feces of children under 5 years of age from Ifakar, Tanzania. J. Clin. Microbiol. 37:3113-3117.[Abstract/Free Full Text]
  32. Ouellette, M., L. Bissonnette, and P. H. Roy. 1987. Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 ß-lactamase gene. Proc. Natl. Acad. Sci. USA 84:7378-7382.[Abstract/Free Full Text]
  33. Perna, N. T., G. Plunkett III, V. Burland, B. Mau, J. M. Glasner, D. J. Rose, G. F. Mayhew, P. S. Evans, J. Gregor, H. A. Kirkpatrick, G. Posfal, J. Hackett, S. Klink, A. Boutin, Y. Shao, L. Miller, E. J. Grotbeck, N. W. Davis, A. Lim, E. T. Dimalanta, K. D. Potamousis, J. Apodaca, T. X. Anantharaman, J. Lin, G. Yen, D. C. Schwartz, R. A. Welch, and F. R. Blattner. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529-533.[CrossRef][Medline]
  34. Pressler, U., H. Staudenmaier, L. Zimmermann, and V. Braun. 1998. Genetics of the iron dicitrate transport system of Escherichia coli. J. Bacteriol. 170:2716-2724.
  35. Priefer, U. 1984. Characterization of plasmid DNA by agarose gel electrophoresis, p. 32-33. In A. Puhler and K. N. Timmis (ed.), Advanced molecular genetics. Springer-Verlag, New York, N.Y.
  36. Rajakumar, K., D. Bulach, J. Davies, L. Ambrose, C. Sasakawa, and B. Adler. 1997. Identification of a chromosomal Shigella flexneri multiantibiotic resistance locus which shares sequence and organizational similarity with the resistance region of the plasmid NR1. Plasmid 37:159-168.[CrossRef][Medline]
  37. Rajakumar, K., C. Sasakawa, and B. Adler. 1996. A spontaneous 99-kb chromosomal deletion results in multi-antibiotic susceptibility and an attenuation of contact haemolysis in Shigella flexneri 2a. J. Med. Microbiol. 45:64-75.[Abstract]
  38. Rakin, A., C. Noelting, P. Schropp, and J. Heesemann. 2001. Integrative module of the high-pathogenicity island of Yersinia. Mol. Microbiol. 39:407-415.[CrossRef][Medline]
  39. Richmond, M. H., P. M. Bennett, C.-L. Choi, N. Brown, J. Brunton, J. Grinsted, and L. Wallace. 1980. The genetic basis of the spread of beta-lactamase synthesis among plasmid-carrying bacteria. Philos. Trans. R. Soc. London Ser. B 289:349-359.[Medline]
  40. Ruzin, A., J. Lindsay, and R. P. Novick. 2001. Molecular genetics of SaPI1—a mobile pathogenicity island in Staphylococcus aureus. Mol. Microbiol. 41:365-377.[CrossRef][Medline]
  41. Salam, M. A., and M. L. Bennish. 1991. Antimicrobial therapy for shigellosis. Rev. Infect. Dis. 13:S332-S341.
  42. Sasakawa, C., K. Kamata, T. Sakai, S. Y. Murayama, S. Makino, and M. Yoshikawa. 1986. Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri. Infect. Immun. 51:470-475.[Abstract/Free Full Text]
  43. Schubert, S., S. Cuenca, D. Fischer, and J. Heesemann. 2000. High-pathogenicity island of Yersinia pestis in Enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J. Infect. Dis. 182:1268-1271.[CrossRef][Medline]
  44. Schubert, S., A. Rakin, H. Karch, E. Carniel, and J. Heesemann. 1998. Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect. Immun. 66:480-485.[Abstract/Free Full Text]
  45. Tanaka, M., K. Matsushita, and T. Yamamoto. 1985. Genesis of a complex transposon encoding the OXA-1 (type II) ß-lactamase gene. Antimicrob. Agents Chemother. 28:227-234.[Abstract/Free Full Text]
  46. Turner, S. A., S. N. Luck, H. Sakellaris, K. Rajakumar, and B. Adler. 2001. Nested deletions of the SRL pathogenicity island of Shigella flexneri 2a. J. Bacteriol. 183:5535-5543.[Abstract/Free Full Text]
  47. Wagegg, W., and V. Braun. 1981. Ferric citrate transport in Escherichia coli requires outer membrane receptor protein FecA. J. Bacteriol. 145:156-163.[Abstract/Free Full Text]
  48. Waldor, M. K., H. Tschape, and J. J. Mekalanos. 1996. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J. Bacteriol. 178:4157-4165.[Abstract/Free Full Text]
  49. Watanabe, T. 1963. Infective heredity of multiple drug resistance in bacteria. Bacteriol. Rev. 27:87-115.
  50. White, P. A., C. J. McIver, and W. D. Rawlinson. 2001. Integrons and gene cassettes in the Enterobacteriaceae. Antimicrob. Agents Chemother. 45:2658-2661.[Abstract/Free Full Text]
  51. Womble, D. D., and R. H. Rownd. 1988. Genetic and physical map of plasmid NR1: comparison with other IncFII antibiotic resistance plasmids. Microbiol. Rev. 52:433-451.[Free Full Text]
  52. Xu, J.-G., B. Cheng, X. Wen, S. Cui, and C. Ye. 2000. High-pathogenicity island of Yersinia spp. in Escherichia coli strains isolated from diarrhea patients in China. J. Clin. Microbiol. 38:4672-4675.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, February 2003, p. 727-734, Vol. 47, No. 2
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.2.727-734.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, S. A.
Right arrow Articles by Adler, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, S. A.
Right arrow Articles by Adler, B.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS